Related Experiment Video

Updated: May 28, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

In the clinic. Management of newly diagnosed HIV infection

Judith Feinberg

    Annals of Internal Medicine
    |October 5, 2011
    PubMed

    Insights

    This clinical overview details the management of newly diagnosed Human Immunodeficiency Virus (HIV) infection. It covers prevention, diagnosis, treatment, and practice improvement strategies for healthcare providers.

    Area of Science:

    • Internal Medicine
    • Infectious Diseases
    • Clinical Practice

    Background:

    • Newly diagnosed Human Immunodeficiency Virus (HIV) infection requires comprehensive management strategies.
    • Effective clinical practice involves integrating prevention, diagnosis, and treatment.
    • Patient information and ongoing education are crucial for managing HIV.

    Purpose of the Study:

    • To provide a clinical overview of the management of newly diagnosed HIV infection.
    • To focus on key aspects including prevention, diagnosis, treatment, and practice improvement.
    • To offer continuing medical education (CME) credits for healthcare professionals.

    Main Methods:

    • Content is derived from established clinical information and education resources.
    • Resources include Physicians' Information and Education Resource (PIER) and Medical Knowledge and Self Assessment Program (MKSAP).
    • Editorial development involves collaboration with the American College of Physicians (ACP) and expert review.

    Main Results:

    • The issue presents a comprehensive clinical overview for managing newly diagnosed HIV.
    • It emphasizes a multi-faceted approach encompassing prevention through treatment.
    • Practice improvement and patient information are integrated into the management guidelines.

    Conclusions:

    • This resource offers essential guidance for clinicians managing newly diagnosed HIV infections.
    • It supports evidence-based practice and enhances patient care.
    • Access to detailed information is available through ACP online resources.

    More Related Videos

    Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors05:46

    Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

    Published on: April 9, 2014

    Related Concept Videos

    Sexually Transmitted Infections01:26

    Sexually Transmitted Infections

    Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
    Retrovirus Life Cycles01:10

    Retrovirus Life Cycles

    Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
    Cryptococcal Meningitis01:27

    Cryptococcal Meningitis

    Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
    Inhibitors of Virion Maturation and Assembly01:19

    Inhibitors of Virion Maturation and Assembly

    As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
    Pulmonary Tuberculosis V01:28

    Pulmonary Tuberculosis V

    Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
    Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
    Trichomoniasis01:18

    Trichomoniasis

    Trichomonas vaginalis is a flagellated protozoan parasite and the causative agent of trichomoniasis, one of the most prevalent non-viral sexually transmitted infections in the United States. This extracellular parasite primarily colonizes the lower genitourinary tract in women—particularly the vagina—and in men, the urethra and prostate. Its structural and functional adaptations enable its survival, motility, and pathogenicity within the host environment.Structural Features and Host EntryT.